Floatz logo

K-13675, (R)-

Intracranial Atherosclerotic Disease (ICAD)

Tokyo Women's Medical UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Intracranial Atherosclerotic Disease (ICAD) cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Yonsei University
Phase 4BBB
Plavix
Yonsei University
Phase 4BB
Apixaban
Yonsei University
Phase 4BB
Rivaroxaban
University of Florida
Phase 3BB
Ticagrelor
University of Florida
Phase 3B

View all 14 →

Same molecule, other indications

K-13675, (R)- is also rated in:

metabolic dysfunction-associated steatotic liver diseaseDormant
CCC
Indicative ·
53 / 100
View asset →
hypertriglyceridemiaDormant
D
Indicative ·
30 / 100
View asset →
stroke disorderDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →